PharmiWeb.com - Global Pharma News & Resources
17-Dec-2018

Innovations in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies, and Adult Stem Cell Regeneration, 2018 Study - ResearchAndMarkets.com

The "Innovations in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies, and Adult Stem Cell Regeneration" report has been added to ResearchAndMarkets.com's offering.

The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across chemotherapy personalization, cell transplantation, multi-drug resistance studies, and adult stem cell regeneration. The corresponding clinical trials scenario related to monoclonal antibody drugs for autoimmune diseases is also depicted.

Key Topics Covered:

1. Recent Advances in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies and Adult Stem Cell Regeneration

Chemotherapy Genetic Interaction Map for Personalized Treatment

Pancreatic Cell Transplant Capable of Vascularization

Decoding Acinetobacter Baumannii's Multi-drug Resistance

Adult Stem Cell Regeneration by Fasting

2. Clinical Trial Analysis and Key Contacts

Clinical Trial Analysis of Monoclonal Antibody Drugs for Autoimmune Diseases

Key Contacts

For more information about this report visit https://www.researchandmarkets.com/research/dwt685/innovations_in?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181217005322/en/

Editor Details

Last Updated: 17-Dec-2018